[1] GROMPE M. Principles of therapeutic liver repopulation[J]. J Inherit Metab Dis, 2006, 29(2/3):421-425.
[2] OERTEL M, MENTHENA A, DABEVA M D, et al. Cell competition leads to a high level of normal liver reconstitution by transplanted fetal liver stem/progenitor cells[J]. Gastroenterology, 2006, 130(2):507-520.
[3] SERRA M P, MARONGIU F, SINI M, et al. Hepatocyte senescence in vivo following preconditioning for liver repopulation[J]. Hepatology, 2012, 56(2):760-768.
[4] WANG M J, CHEN F, LIU Q G, et al. Insulin-Like growth factor 2 is a key mitogen driving liver repopulation in mice[J]. Cell Death Dis, 2018, 9(2):26.
[5] PADRISSA-ALTéS S, BACHOFNER M, BOGORAD R L, et al. Control of hepatocyte proliferation and survival by Fgf receptors is essential for liver regeneration in mice[J]. Gut, 2015, 64(9):1444-1453.
[6] RHIM J A, SANDGREN E P, DEGEN J L, et al. Replacement of diseased mouse liver by hepatic cell transplantation[J]. Science, 1994, 263(5150):1149-1152.
[7] KATSUDA T, KAWAMATA M, HAGIWARA K, et al. Conversion of terminally committed hepatocytes to culturable bipotent progenitor cells with regenerative capacity[J]. Cell Stem Cell, 2017, 20(1):41-55.
[8] OVERTURF K, AL-DHALIMY M, TANGUAY R, et al. Hepatocytes corrected by gene therapy are selected in vivo in a murine model of hereditary tyrosinaemia type I[J]. Nat Genet, 1996, 12(3):266-273.
[9] YU B, HE Z Y, YOU P, et al. Reprogramming fibroblasts into bipotential hepatic stem cells by defined factors[J]. Cell Stem Cell, 2013, 13(3):328-340.
[10] HU H L, GEHART H, ARTEGIANI B, et al. Long-term expansion of functional mouse and human hepatocytes as 3D organoids[J]. Cell, 2018, 175(6):1591-1606.
[11] PAULK N K, WURSTHORN K, HAFT A, et al. In vivo selection of transplanted hepatocytes by pharmacological inhibition of fumarylace-toacetate hydrolase in wild-type mice[J]. Mol Ther, 2012, 20(10):1981-1987.
[12] CHEN S L, SHAO C H, DONG T F, et al. Transplantation of ATP7B-transduced bone marrow mesenchymal stem cells decreases copper overload in rats[J]. PLoS One, 2014, 9(11):e111425.
[13] BOREL F, TANG Q S, GERNOUX G, et al. Survival advantage of both human hepatocyte xenografts and genome-edited hepatocytes for treatment of α-1 antitrypsin deficiency[J]. Mol Ther, 2017, 25(11):2477-2489.
[14] SHI D Y, ZHANG J N, ZHOU Q, et al. Quantitative evaluation of human bone mesenchymal stem cells rescuing fulminant hepatic failure in pigs[J]. Gut, 2017, 66(5):955-964.
[15] HWANG Y, KIM J C, TAE G. Significantly enhanced recovery of acute liver failure by liver targeted delivery of stem cells via heparin functionalization[J]. Biomaterials, 2019, 209:67-78.
[16] YOVCHEV M I, XUE Y H, SHAFRITZ D A, et al. Repopulation of the fibrotic/cirrhotic rat liver by transplanted hepatic stem/progenitor cells and mature hepatocytes[J]. Hepatology, 2014, 59(1):284-295.
[17] GUO D Q, FU T, NELSON J A, et al. Liver repopulation after cell transplantation in mice treated with retrorsine and carbon tetrachloride[J]. Transplantation, 2002, 73(11):1818-1824.
[18] CHEN Y H, CHEN H L, CHIEN C S, et al. Contribution of mature hepatocytes to biliary regeneration in rats with acute and chronic biliary injury[J]. PLoS One, 2015, 10(8):e0134327.
[19] WITEK R P, FISHER S H, PETERSEN B E. Monocrotaline, an alternative to retrorsine-based hepatocyte transplantation in rodents[J]. Cell Transplant, 2005, 14(1):41-47.
[20] KRAUSE P, RAVE-FRANK M, CHRISTIANSEN H, et al. Preconditioning of the liver for efficient repopulation by primary hepatocyte transplants[J]. Methods Mol Biol, 2014, 1213:29-39.
[21] BARAHMAN M, ZHANG W, HARRIS H Y, et al. Radiation-primed hepatocyte transplantation in murine monogeneic dyslipidemia normalizes cholesterol and prevents atherosclerosis[J]. J Hepatol, 2019, 70(6):1170-1179.
[22] SERRA M P, MARONGIU F, SINI M, et al. Hepatocyte senescence induced by radiation and partial hepatectomy in rat liver[J]. Int J Radiat Biol, 2014, 90(10):876-883.
[23] SERRA M P, MARONGIU F, MARONGIU M, et al. Cell-autonomous decrease in proliferative competitiveness of the aged hepatocyte[J]. J Hepatol, 2015, 62(6):1341-1348.
[24] MENTHENA A, KOEHLER C I, SANDHU J S, et al. Activin A, p15INK4b signaling, and cell competition promote stem/progenitor cell repopulation of livers in aging rats[J]. Gastroenterology, 2011, 140(3):1009-1020.
[25] LU W Y, BIRD T G, BOULTER L, et al. Hepatic progenitor cells of biliary origin with liver repopulation capacity[J]. Nat Cell Biol, 2015, 17(8):971-983.
[26] CHEN J J, YANG T, SONG S H, et al. Senescence suppressed proliferation of host hepatocytes is precondition for liver repopulation[J]. Biochem Biophys Res Commun, 2019, 516(2):591-598.
[27] YUAN R H, OGAWA A, OGAWA E, et al. P27Kip1 inactivation provides a proliferative advantage to transplanted hepatocytes in DPPIV/Rag2 double knockout mice after repeated host liver injury[J]. Cell Transplant, 2003, 12(8):907-919.
[28] XIANG D, LIU C C, WANG M J, et al. Non-viral FoxM1 gene delivery to hepatocytes enhances liver repopulation[J]. Cell Death Dis, 2014, 5:e1252.
[29] YOVCHEV M, JABER F L, LU Z L, et al. Experimental model for successful liver cell therapy by lenti TTR-YapERT2 transduced hepatocytes with tamoxifen control of Yap subcellular location[J]. Sci Rep, 2016, 6:19275.
[30] WILKINSON P D, DELGADO E R, ALENCASTRO F, et al. The polyploid state restricts hepatocyte proliferation and liver regeneration in mice[J]. Hepatology, 2019, 69(3):1242-1258.
[31] BOYLAN J M, FRANCOIS-VAUGHAN H, GRUPPUSO P A, et al. Engraftment and repopulation potential of late gestation fetal rat hepatocytes[J]. Transplantation, 2017, 101(10):2349-2359.
[32] NIERHOFF D, OGAWA A, OERTEL M, et al. Purification and characterization of mouse fetal liver epithelial cells with high in vivo repopulation capacity[J]. Hepatology, 2005, 42(1):130-139.
[33] HERRERO A, PRIGENT J, LOMBARD C, et al. Adult-derived human liver stem/progenitor cells infused 3 days postsurgery improve liver regeneration in a mouse model of extended hepatectomy[J]. Cell Transplant, 2017, 26(2):351-364.
[34] JOSHI M, OLTEAN M, PATIL P B, et al. Chemokine-mediated robust augmentation of liver engraftment:a novel approach[J]. Stem Cells Transl Med, 2015, 4(1):21-30.
[35] STOCK P, BIELOHUBY M, STAEGE M S, et al. Impairment of host liver repopulation by transplanted hepatocytes in aged rats and the release by short-term growth hormone treatment[J]. Am J Pathol, 2017, 187(3):553-569.
[36] BAHDE R, KAPOOR S, BANDI S, et al. Directly acting drugs prostacyclin or nitroglycerine and endothelin receptor blocker bosentan improve cell engraftment in rodent liver[J]. Hepatology, 2013, 57(1):320-330.
[37] BAHDE R, KAPOOR S, VISWANATHAN P, et al. Endothelin-1 receptor A blocker darusentan decreases hepatic changes and improves liver repopulation after cell transplantation in rats[J]. Hepatology, 2014, 59(3):1107-1117.
[38] VISWANATHAN P, KAPOOR S, KUMARAN V, et al. Etanercept blocks inflammatory responses orchestrated by TNF-α to promote transplanted cell engraftment and proliferation in rat liver[J]. Hepatology, 2014, 60(4):1378-1388.
[39] VISWANATHAN P, GUPTA P, KAPOOR S, et al. Thalidomide promotes transplanted cell engraftment in the rat liver by modulating inflammation and endothelial integrity[J]. J Hepatol, 2016, 65(6):1171-1178.
[40] LEE C, DHAWAN A, IANSANTE V, et al. Improving engraftment of hepatocyte transplantation using alpha-1 antitrypsin as an immune modulator[J]. J Mol Med, 2019, 97(4):563-577. |
